Saveurs et Vie has completed a fundraising
August 2013 — Saveurs et Vie has completed a fundraising with Isatis Capital to develop a new product line and fund acquisitions.
Saveurs et Vie is a leading home care services company specialized in preparing and delivering meals for senior people. The company buys ready-meals from various suppliers and assembles complete meals according to the medical needs of the clients, mostly senior people. Saveurs et Vie acquires news customers directly (B2C) or through contracts with local authorities (B2B2C). The company is the largest in France in this field and has recently developed services for hospitals to help them cope with under-nourished patients.
Our role in the transaction
Oaklins’ team in France advised Saveurs et Vie on its fundraising. The team contacted nearly 25 potential investors, 10 of them showed interest and were ready to send a non-binding offer.
Talk to the deal team
Related deals
KPS Food Group has joined ForFarmers Polska, a joint venture controlled by ForFarmers N.V.
ForFarmers N.V. has strengthened its position in Poland’s growing poultry market through the establishment of a joint venture with KPS Food Group, a leading poultry producer with operations spanning farming, slaughtering and food processing. ForFarmers’ existing Polish joint venture, Tasomix, and KPS’s operations have been combined to form ForFarmers Polska, which has an enterprise value of approximately US$585 million. ForFarmers holds a controlling 50.5% stake and will fully consolidate the joint venture. The founders of KPS and Tasomix remain minority shareholders.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreTandem has completed a voluntary public tender offer for the shares of Compagnia dei Caraibi
Tandem S.r.l. has completed a voluntary public tender offer for 25.99% of the shares in Compagnia dei Caraibi S.p.A.
Learn more